Can sorafenib be discontinued in hepatocellular carcinoma patients with a complete response to treatment?

References

[1] Llovet JM,Mazzaferro V,Gane E,de Oliveira AC,Raoul JL,Schwartz M,Zeuzem S,Greten TF,Seitz JF,Häussinger D,Shan M,Voliotis D.Sorafenib in advanced hepatocellular carcinoma..N Engl J Med2008;359:378-90

[2] Cheng AL,Chen Z,Qin S,Luo R,Ye S,Xu J,Liang H,Wang J,Pan H,Zou J,Guan Z.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial..Lancet Oncol2009;10:25-34

[3] Zhang L,Chen X.Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis..PLoS One2014;9:e100305 PMCID:PMC4063775

[4] Chao Y,Han G,Yang J,Shao GL,Lee TY.The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial..Int J Cancer2015;136:1458-67

[5] Kudo M.Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan..Oncology2010;78 Suppl 1:154-66

[6] Johannsen M,Bex A,Cosentino M,Kloeters C,Rogalla P,Grünwald V.Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis..Eur Urol2009;55:1430-8

[7] So BJ,Bloomston MA.Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: a case report..J Hematol Oncol2008;1:18 PMCID:PMC2575202

[8] Wang SX,Verma S,Rixe O.Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report..Target Oncol2010;5:59-63

[9] Sacco R,Gianluigi G,Bozzi E,Battaglia V,Bertoni M,Bresci G.Complete response for advanced liver cancer during sorafenib therapy: case report..BMC Gastroenterol2011;11:4 PMCID:PMC3036648

[10] Inuzuka T,Sekikawa A,Henmi S,Saito S,Kimura T,Kudo M.Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report..Oncology2011;81 Suppl 1:152-7